When Standard Options End, New Possibilities Begin
A secure, HIPAA-aligned portal connecting oncologists to global treatment intelligence. Submit de-identified cases for peer review by 2-3 specialists, match patients to one of the world's largest CAR-T clinical trial ecosystems, and coordinate treatment at 200+ partner institutions across 8 countries. Free for referring physicians.
Three Core Services
Comprehensive tools to expand treatment options for your patients with advanced cancer.
Patient Referral
Securely refer patients for treatment at partner institutions. We handle logistics while you retain clinical oversight throughout the journey.
- Secure case submission portal
- Transparent cost estimates from multiple centers
- Travel, visa, and accommodation coordination
- Multi-language patient support
- Ongoing case updates to referring physician
- Direct physician-to-physician communication
Peer Case Review
Submit de-identified cases for independent evaluation by 2-3 specialist oncologists. Receive PubMed-cited recommendations within 48-72 hours.
- 2-3 independent specialist opinions
- Reduced bias through consensus methodology
- Evidence-based with PubMed citations
- Clinical trial eligibility assessment
- Multi-country treatment landscape view
- Optional physician-to-physician consultation
Clinical Trial Matching
Match patients to appropriate clinical trials across our network. Access one of the world's largest CAR-T trial ecosystems, alongside studies in seven additional countries.
- 700+ CAR-T trials in China alone
- Trials across 8 countries
- Eligibility criteria matching
- Real-time availability updates
- Next-generation therapy options
- Enrollment coordination support
Oncology Areas Covered
Our network spans hematologic malignancies, solid tumors, and rare cancers. Peer review is available across all listed areas.
Hematologic Malignancies
- DLBCL (Diffuse Large B-Cell Lymphoma)
- ALL (Acute Lymphoblastic Leukemia)
- AML (Acute Myeloid Leukemia)
- Multiple Myeloma
- Mantle Cell Lymphoma
- Follicular Lymphoma
Solid Tumors
- Lung Cancer (NSCLC & SCLC)
- Pancreatic Cancer
- Gastric / Gastroesophageal Cancer
- Liver Cancer (HCC)
- Colorectal Cancer
- Glioblastoma
Rare & Other Cancers
- Sarcoma
- Cholangiocarcinoma
- Neuroendocrine Tumors
- Breast Cancer (Triple-Negative)
- Ovarian Cancer
- Mesothelioma
Why Join the Physician Portal?
Benefits designed to support your clinical practice and expand patient options.
Global Network Access
Connect with 200+ partner institutions across 8 countries. Access treatments and trials unavailable locally.
Completely Free
No subscription fees, no per-case charges, no hidden costs. All services are free for licensed physicians.
Rapid Response
48-72 hour peer review turnaround. Urgent cases expedited within 24 hours. Real-time trial availability.
Evidence-Based
All recommendations include PubMed citations, NCCN/ESMO/ASCO guideline references, and clinical trial data.
HIPAA-Aligned Security
End-to-end encryption, de-identified data, secure document upload, role-based access, and complete audit trails.
Physician Autonomy
We support your clinical judgment, never override it. All medical decisions remain with the treating physician.
Direct Communication
Physician-to-physician consultation with treating specialists abroad. No intermediaries, no barriers.
Outcome Data
Access anonymized outcome data including response rates, progression-free survival, and adverse event profiles.
How Is This Service Funded?
We understand that physicians need complete transparency. CancerCareE does not charge physicians for case review, referral coordination, or trial matching. Our platform is sustained through institutional partnerships with hospitals. In some cases, partner institutions may compensate CancerCareE for administrative and coordination services.
Clinical recommendations are developed independently and are not influenced by financial arrangements. Referring physicians and their patients are never charged any fees.
Peer Review Methodology & Outcome Data
Transparency in how we develop clinical recommendations.
Peer Review Methodology
- Independent Review: Each case is evaluated independently by 2-3 specialist oncologists.
- Conflict-of-Interest Declaration: All reviewers declare any potential conflicts before case assignment.
- Evidence Hierarchy: Recommendations are based on systematic review of published literature, clinical guidelines, and trial data.
- Consensus Process: When reviewer opinions differ, a structured consensus process is used.
What Outcome Data Is Available?
Physicians with portal access can review anonymized aggregated outcome data, where available:
- Response rates (CR, PR)
- Progression-free survival (PFS)
- Adverse event profiles (CTCAE graded)
- Treatment completion rates
- Follow-up duration
Availability of specific outcome data varies by institution and clinical study.
Sample Cases
Real examples of how our platform has connected physicians and patients to global treatment options.
Relapsed DLBCL After Second-Line Therapy
Advanced HCC with GPC3 Expression
Metastatic Gastric Cancer
Who Can Join the Portal?
Clear criteria to ensure quality and security for all participants.
Eligible Physicians
- Board-certified oncologists (medical, radiation, surgical)
- Board-certified hematologists
- Active, unrestricted medical license
- Verified institutional affiliation
- Specialists in cellular therapy or immunotherapy
- Physicians treating rare or complex cancers
- Academic researchers in oncology
- Clinical trial investigators
Not Eligible
- Non-licensed practitioners
- Physicians with restricted or suspended licenses
- Alternative medicine providers without oncology certification
- Unverified institutional affiliations
- Commercial entities seeking patient data
- Individuals misrepresenting credentials
- Non-physician healthcare providers (unless co-sponsored)
How to Get Started
Simple 4-step process to access the physician portal.
Submit Application
Complete the physician application form with your credentials, license information, and institutional affiliation.
Credential Verification
Our team verifies your medical license, board certification, and institutional affiliation within 24-48 hours.
Portal Access
Upon approval, receive secure login credentials for the physician portal with full access to all services.
Start Using Services
Submit cases for peer review, refer patients, or match to clinical trials. All services are free and unlimited.
Our Global Network
200+ partner institutions across 8 countries, including public hospitals, private centers, and clinical trial sites.
China
India
Turkey
South Korea
USA
Germany
Singapore
Security & Compliance
Your patients' data is protected with enterprise-grade security and strict privacy protocols.
End-to-End Encryption
256-bit SSL encryption for all data transmission. Files encrypted at rest and in transit. Secure upload portal with virus scanning.
De-identified Data
All case submissions use de-identified patient data. No personally identifiable information (PII) shared without explicit consent.
Role-Based Access
Only authorized personnel can view case information. Multi-factor authentication required for all portal access.
Complete Audit Trails
Comprehensive logs of all data access and modifications. Regular security audits conducted. Full transparency.
Legal Agreements
Business Associate Agreements (BAA) available. GDPR-compliant for European patients. Comprehensive confidentiality agreements.
Data Retention Policy
Protected health information (PHI) not stored longer than necessary. Secure deletion after case closure per policy.
Frequently Asked Questions
Common questions from physicians about our portal and services.
The CancerCareE Physician Portal is a secure, HIPAA-aligned platform for licensed oncologists and hematologists to refer patients, request peer case reviews by 2-3 specialists, and match patients to clinical trials across our network of 200+ partner institutions in 8 countries. All services are free for referring physicians.
CancerCareE is sustained through institutional partnerships with hospitals and administrative coordination fees from partner institutions. Clinical recommendations are developed independently and are not influenced by financial arrangements. Referring physicians and their patients are never charged any fees.
Physicians can access anonymized aggregated outcome data where available, including response rates (CR, PR), progression-free survival (PFS), adverse event profiles (CTCAE graded), treatment completion rates, and follow-up duration. Availability varies by institution and clinical study.
The portal is available to board-certified oncologists, hematologists, and related specialists with active, unrestricted medical licenses. Applicants must provide verification of credentials including medical license number, board certification, and institutional affiliation. Verification typically takes 24-48 hours.
We use HIPAA-aligned security protocols including end-to-end encryption, de-identification of patient data, secure document upload, role-based access controls, and complete audit trails. All reviewers and staff sign comprehensive confidentiality agreements. We do not store protected health information (PHI) longer than necessary.
CancerCareE is an access coordination platform, not a healthcare provider. We do not diagnose, treat, or make medical decisions. We facilitate connections between physicians, patients, and partner institutions. All medical decisions remain with the treating physician.
Ready to Expand Treatment Options for Your Patients?
Join our network of referring physicians and access global oncology intelligence. Free for licensed oncologists.
HIPAA-aligned security • Free for physicians • 24-48h verification • 48-72h peer review